Gian Residency Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 01-01-2025
- Paid Up Capital ₹ 0.49 M
as on 01-01-2025
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 27.78 Cr
as on 01-01-2025
- Satisfied Charges ₹ 29.94 Cr
as on 01-01-2025
- Revenue 15.48%
(FY 2020)
- Profit 90.04%
(FY 2020)
- Ebitda -24.73%
(FY 2020)
- Net Worth -1.48%
(FY 2020)
- Total Assets 0.28%
(FY 2020)
About Gian Residency
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹27.78 Cr. The company has closed loans amounting to ₹29.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vasu Trehan, Neeraj Trehan, and Umesh Trehan serve as directors at the Company.
- CIN/LLPIN
U70101CH2000PTC023794
- Company No.
023794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationChandigarh, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gian Residency?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasu Trehan  | Managing Director | 12-Sep-2005 | Current |
| Umesh Trehan | Managing Director | 26-Jun-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Trehan | Director | 26-Jun-2000 | Current |
Financial Performance of Gian Residency.
Gian Residency Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.48% increase. The company also saw a substantial improvement in profitability, with a 90.04% increase in profit. The company's net worth dipped by a decrease of 1.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gian Residency?
In 2020, Gian Residency had a promoter holding of 87.68% and a public holding of 12.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gcak Trading Private LimitedActive 15 years 11 monthsVasu Trehan and Umesh Trehan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 18 Oct 2024 | ₹5.00 Cr | Open |
Others Creation Date: 27 Oct 2021 | ₹13.40 Cr | Open |
Others Creation Date: 07 Sep 2018 | ₹6.50 Cr | Open |
How Many Employees Work at Gian Residency?
Gian Residency has a workforce of 29 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gian Residency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gian Residency's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
